<PAGE> 1
2983
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number 0-11371
CUSIP Number 090908
NOTIFICATION OF LATE FILING
(Check One): /X/ Form 10-K and Form 10-KSB / / Form 20-F / / Form 11-K
/ / Form 10-Q and Form 10-QSB / / Form N-SAR
For Period Ended DECEMBER 31, 1998
/ / Transition Report on Form 10-K / / Transition Report on Form 10-Q
/ / Transition Report on Form 20-F / / Transition Report on Form N-SAR
/ / Transition Report on Form 11-K
For the Transition Period Ended:______________________________________________
Read the attached instruction sheet before preparing form. Please print
or type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above
identify the Item(s) to which the notification relates:
____________________________________________________________________________
____________________________________________________________________________
PART I. REGISTRANT INFORMATION
Full name of registrant BIOSONICS, INC.
Former name if applicable ____________________________________________________
Address of principal executive office (Street and number):
185 COMMERCE DRIVE, SUITE 103
City, State and Zip Code: FT. WASHINGTON, PA 19034
PART II. RULE 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
/X/ (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
/X/ (b) The subject annual report, semi-annual report, transition report on
Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the 15th calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q, or portion thereof will be
filed on or before the fifth calendar day following the prescribed due date;
and
/X/ (c) The accountant's statement or other exhibit required by Rule
12b-25(c)has been attached if applicable.
PART III. NARRATIVE
State below in reasonable detail the reasons why From 10-K, 11-K, 20-F,
10-Q, N-SAR or the transition report portion thereof could not be filed within
the predescribed time period. (Attach extra sheets if needed.)
THE COMPANY WAS UNABLE TO OBTAIN THIRD PARTY INFORMATION
THEREFORE DELAYING THE INDEPENDENT AUDITORS FROM COMPLETING THEIR
OPINION OF THE FINANCIAL STATEMENTS.
<PAGE> 2
PART IV. OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
SANDRA PILEGGI 215 646-7100
(Name) (Area code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during preceding 12 months or for such shorter period that the
registrant was required to file such report been filed? If the answer is no,
identify report(s). /X/ Yes / / No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof? / / Yes /X/ No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
BIOSONICS, INC.
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: 4/30/99 By: /S/JACK PALLER CHIEF EXECUTIVE OFFICER
Instruction. The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and title
of the person signing the form shall be typed or printed beneath the
signature. If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
